Page last updated: 2024-12-06
sulfaproxyline
Description
Research Excerpts
Clinical Trials
Roles
Classes
Pathways
Study Profile
Bioassays
Related Drugs
Related Conditions
Protein Interactions
Research Growth
Market Indicators
Description
sulfaproxyline: structure given in first source [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]
Cross-References
ID Source | ID |
---|---|
PubMed CID | 67002 |
CHEMBL ID | 2107520 |
SCHEMBL ID | 149839 |
MeSH ID | M0149166 |
Synonyms (47)
Synonym |
---|
nsc-120646 |
sulfaproxylin |
p-[(4-isopropoxybenzoyl)amino]benzenesulfonamide |
n(sup1)-(4-isopropoxybenzoyl)sulfanilamide |
benzamide, n-[(4-aminophenyl)sulfonyl]-4-(1-methylethoxy)- |
n(sup1)-(4-isopropoxybenzoyl)-p-aminobenzenesulfonamide |
116-42-7 |
p-isopropoxy-n-sulfanilylbenzamide |
sulfaproxyline |
benzamide, p-isopropoxy-n-sulfanilyl- |
sulphaproxyline |
n(sup1)-(p-isopropoxybenzoyl)sulfanilamide |
nsc120646 |
g 13289 |
n-(4-aminophenyl)sulfonyl-4-propan-2-yloxybenzamide |
p-((4-isopropoxybenzoyl)amino)benzenesulfonamide |
sulfaproxilina [inn-spanish] |
sulfaproxylinum |
nsc 120646 |
sulfaproxylinum [inn-latin] |
g 14289 |
n1-(4-isopropoxybenzoyl)sulfanilamide |
einecs 204-140-5 |
benzamide, n-((4-aminophenyl)sulfonyl)-4-(1-methylethoxy)- |
sulfaproxilina |
sulfaproxyline [inn:ban] |
n(sup 1)-(4-isopropoxybenzoyl)sulfanilamide |
yr841r53vw , |
unii-yr841r53vw |
CHEMBL2107520 |
SCHEMBL149839 |
sulfaproxyline [who-dd] |
sulfaproxyline [mi] |
sulfaproxyline [inn] |
sulfaproxylin;sulfaproxyline |
HY-101829 |
sulfaproxiline |
CS-6583 |
AS-70510 |
n-(4-aminobenzenesulfonyl)-4-(propan-2-yloxy)benzamide |
n-(4-aminobenzene-1-sulfonyl)-4-[(propan-2-yl)oxy]benzamide |
DTXSID70861746 |
Q27294674 |
D92833 |
EX-A4500 |
AKOS037646728 |
n-((4-aminophenyl)sulfonyl)-4-isopropoxybenzamide |
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]
Research
Studies (5)
Timeframe | Studies, This Drug (%) | All Drugs % |
---|---|---|
pre-1990 | 5 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |
Market Indicators
Research Demand Index: 12.66
According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be weak demand-to-supply ratio for research on this compound.
| This Compound (12.66) All Compounds (24.57) |
Study Types
Publication Type | This drug (%) | All Drugs (%) |
---|---|---|
Trials | 0 (0.00%) | 5.53% |
Reviews | 0 (0.00%) | 6.00% |
Case Studies | 0 (0.00%) | 4.05% |
Observational | 0 (0.00%) | 0.25% |
Other | 5 (100.00%) | 84.16% |
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023] |